Location History:
- Rixensart, BE (1999 - 2005)
- Brussles, BE (2005)
- Brussels, BE (1994 - 2012)
Company Filing History:
Years Active: 1994-2012
Title: Benoit Van Den Eynde: A Pioneer in Cancer Immunotherapy
Introduction
Benoit Van Den Eynde is a prominent researcher based in Brussels, Belgium, recognized for his significant contributions to the field of cancer immunotherapy. With a remarkable portfolio of 27 patents, he has made groundbreaking advancements aimed at improving cancer treatment and diagnosis.
Latest Patents
Among his notable inventions are the following:
1. **MAGE-C2 Antigenic Peptides and Uses Thereof**: This invention focuses on isolated peptides derived from MAGE-C2, nucleic acid molecules that encode these peptides, and expression vectors containing these nucleic acids. It also involves host cells transformed with these nucleic acids and tetramers comprising the peptides, HLA molecules, β2-microglobulin, and binding partners. The patents discuss methods of using these components, which include cytolytic T cells capable of recognizing the peptides in complex with an HLA molecule.
2. **Isolated Tumor Rejection Antigen Precursor Proteins MAGE-2 and MAGE-3**: This invention relates to an isolated DNA sequence coding for an antigen that is expressed by tumor cells, recognized by cytotoxic T cells, which facilitates the lysis of these tumor cells. Additionally, the invention describes cells that are transfected with this DNA sequence and outlines various therapeutic and diagnostic applications derived from its properties.
Career Highlights
Benoit Van Den Eynde currently works at the Ludwig Institute for Cancer Research Limited, where he continues to explore innovative approaches to cancer therapy. His journey in the field has been filled with significant discoveries that pave the way for potential clinical applications.
Collaborations
Throughout his career, Van Den Eynde has collaborated with esteemed colleagues, including Thierry R Boon-Falleur and Pierre Van Der Bruggen. These partnerships have significantly enriched his research endeavors and expanded the impact of his innovations on cancer immunotherapy.
Conclusion
Benoit Van Den Eynde stands out as a leading figure in the realm of cancer research, with numerous patents that highlight his commitment to fighting cancer through innovative approaches. His work serves as an inspiration for future researchers and underscores the importance of continuous innovation in medical science.